Carrier Screening Market Growth, Business Opportunities, Competitive Landscape and Industry Analysis Report by 2027
Emergen Research Logo
Market Trends – Growing awareness of carrier screening across the healthcare industry
VANCOUVER, BC, UNITED STATES, May 25, 2022 /EINPresswire.com/ --
The Global Carrier Screening Market will be worth USD 6.13 billion by 2027, according to a current analysis by Emergen Research.
The market is positively affected by a few key parameters. The main biotechnological companies are trying to introduce and emphasise on a wide variety of affordable and technologically advanced screening test kits along with the solutions in order to keep a tab on the growing emergence of genetic disorders. However, in developing economies, the growing urbanization is leading to changing lifestyles, which often impacts pregnant women during the phase. Hence, in order to initially detect and diagnose a disease, doctors across the globe are emphasising on the usage of carrier screening tests.
Moreover, as a result of the testing kits becoming more advanced and cost-effective, the carrier screening market is predicted to grow significantly throughout the forecast period because of the minimized expenditure on tests and effective efficiency that are propelling the demand for them among people planning a family.
You Can Download Free Sample PDF Copy Of This Report At: https://www.emergenresearch.com/request-sample/235
The study further explores and provides an in-depth analysis of current market dynamics and recent trends, focusing on various key factors and potential growth opportunities and risks. The report focuses on leading regions and their major countries to anticipate market growth in the forecast years.
Key participants MedGenome Inc., Luminex Corporation, Illumina Inc., Otogenetics Corporation, Myriad Genetics Inc., Thermo Fisher Scientific Inc., Natera Inc., Gene By Gene Ltd., Corporation of America Holdings, and Mount Sinai Genomics Inc., among others.
Highlights from the Report
In November 2019, Asuragen, a molecular diagnostics company based out of the U.S. launched the AmplideX® PCR/CE SMN1/2 Plus Kit. The technology helps in the early detection of variants associated with SMN1 gene duplication events as well as quantify numbers related to SMN1 and SMN2. By providing results from a single PCR reaction, the technology helps to increase efficiency by reducing time and effort.
The growth across the carrier screening bifurcation is estimated to continue to contribute to the growth of the market until 2030 due to the fact that, with this approach, tests for multiple genetic diseases can be carried out at once. The dominance of the market segment is also because of the heavy utilization of the next-generation sequencing (NGS) technique for genetic disease screening.
Over the forecast period, the DNA sequencing segment is anticipated to witness the highest market share in terms of revenue in the carrier screening market because of the number of patents rising on an incremental scale across European and North American regions.
Request a discount on the report @ https://www.emergenresearch.com/request-discount/235
The report studies the historical data of the Carrier Screening Market and offers valuable information about the key segments and sub-segments, revenue generation, demand and supply scenario, trends, and other vital aspects.
For the purpose of this report, Emergen Research has segmented the Global Carrier Screening Market on the technology, end-user, medical condition, and region:
Technology Outlook (Revenue, USD Billion; 2017-2027)
DNA Sequencing
Polymerase Chain Reaction
Microarrays
Others
End-User Outlook (Revenue, USD Billion; 2017-2027)
Hospitals
Reference Laboratories
Physician Offices and Clinics
Others
Medical Condition Outlook (Revenue, USD Billion; 2017-2027)
Pulmonary Conditions
Hematological Conditions
Neurological Conditions
Others
Geographical Segmentation:
The latest research report entails an in-depth analysis of the current growth opportunities for various regions of the Energy as a Service Market, gauging their revenue share over the forecast timeline. Furthermore, the report analyses the year-on-year growth rate of these regions over the forecast duration. The leading market regions profiled in the report are North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The report offers a comprehensive understanding of the impact of the COVID-19 pandemic on the overall market growth and expansion. COVID-19 has affected the global economy by interfering with production and demand, causing market disruption, and inducing financial instability.
Request customization of the report @ https://www.emergenresearch.com/request-for-customization/235
Key Points of Carrier Screening Market:
Key insights into the regional spread of the industry in key geographies
Radical insights into the vital market trends; both current and emerging trends, and factors influencing the growth of the market
Complete data about the key manufacturers and vendors in the Carrier Screening market
Thank you for reading our report. Customization of the report is available. To know more, please connect with us, and our team will ensure the report is customized as per your requirements.
Take a Look at our Related Reports:
Point of Care Testing Market
Injectable Drug Delivery Market
Interventional Cardiology Market
3D Printing Market
https://www.google.com.ag/url?q=https://www.emergenresearch.com/industry-report/3d-printing-market
Assistive Reproductive Technology Market
Quantum Dots Market
https://www.google.com.ag/url?q=https://www.emergenresearch.com/industry-report/quantum-dots-market
Inhalation and Nasal Spray Market
Cloud Data Back-Up Recovery Market
About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Eric Lee
Emergen Research
+91 90210 91709
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.
